| 摘要 |
A pharmaceutical preparation comprises ciclopirox olamine, and one or more of: vasco-epithelial growth factor (VEGF), a VEGF biomimetic, and/or a VEGFR2 receptor agonist, in a physiologically acceptable medium. The composition may also comprise one or more catalases or mimetics thereof, superoxide dismutases or mimetics thereof, one or more antioxidants, one or more 5 alpha reductase inhibitors, one or more nitric oxide synthases, a UV protective material, and/or a penetration enhancing ingredient, such as salicylic acid. The composition may be for use in: autologous growth factor therapy; the prevention of hair loss; for improving skin blemishes; or treatment of damage to skin cells associated with accumulation of reactive oxygen or nitrogen specifies. It may also be used for soaking follicular grafts prior to implantation; for improving survival rates of implanted hair follicles, to improve wound healing times; or to prepare grafts for removal prior to hair transplant surgery.
|
